Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Generex Biotechnology Corp. (GNBT)
OTHER OTC:GNBT
Generex Biotechnology (GNBT) Financial Statements
0 Followers
Generex Biotechnology Financial Overview
| Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 20.70K | $ 0.00 | $ 88.44K | $ 583.63K | $ 498.68K |
| Gross Profit | $ -45.30K | $ -104.98K | $ 65.10K | $ 419.34K | $ 382.38K |
| EBIT | $ 9.54M | $ -23.82M | $ -9.97M | $ -10.23M | $ -4.25M |
| EBITDA | $ 9.82M | $ -23.54M | $ -9.69M | $ -9.91M | $ -4.03M |
| Net Income Common Stockholders | $ 9.22M | $ -24.08M | $ -10.73M | $ -11.67M | $ -5.63M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 1.68M | $ 596.03K | $ 833.57K | $ 15.45K | $ 416.64K |
| Total Assets | $ 45.92M | $ 45.51M | $ 45.89M | $ 45.38M | $ 51.90M |
| Total Debt | $ 9.29M | $ 10.77M | $ 10.51M | $ 11.23M | $ 12.23M |
| Net Debt | $ 7.61M | $ 10.17M | $ 9.68M | $ 11.22M | $ 11.82M |
| Total Liabilities | $ 94.08M | $ 104.70M | $ 81.99M | $ 57.34M | $ 54.85M |
| Stockholders Equity | $ -56.33M | $ -68.10M | $ -45.35M | $ -21.46M | $ -12.66M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 576.69K | $ -980.18K | $ -1.34M | $ -634.22K | $ -866.92K |
| Operating Cash Flow | $ 576.69K | $ -980.18K | $ -1.34M | $ -634.22K | $ -866.92K |
| Investing Cash Flow | - | - | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 502.30K | $ 740.45K | $ 2.16M | $ 244.97K | $ 1.02M |
Generex Biotechnology Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.